HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma.

Abstract
Synthetic lethal interaction provides a conceptual framework for the development of wiser cancer therapeutics. In this study, we exploited a therapeutic strategy based on the interaction between GATA binding protein 2 (GATA2) downregulation and the KRAS mutation status by delivering small interfering RNA targeting GATA2 (siGATA2) with cationic lipid-assisted polymeric nanoparticles for treatment of non-small-cell lung carcinoma (NSCLC) harboring oncogenic KRAS mutations. Nanoparticles carrying siGATA2 (NPsiGATA2) were effectively taken up by NSCLC cells and resulted in targeted gene suppression. NPsiGATA2 selectively inhibited cell proliferation and induced cell apoptosis in KRAS mutant NSCLC cells. However, this intervention was harmless to normal KRAS wild-type NSCLC cells and HL7702 hepatocytes, confirming the advantage of synthetic lethality-based therapy. Moreover, systemic delivery of NPsiGATA2 significantly inhibited tumor growth in the KRAS mutant A549 NSCLC xenograft murine model, suggesting the therapeutic promise of NPsiGATA2 delivery in KRAS mutant NSCLC therapy.
AuthorsSong Shen, Chong-Qiong Mao, Xian-Zhu Yang, Xiao-Jiao Du, Yang Liu, Yan-Hua Zhu, Jun Wang
JournalMolecular pharmaceutics (Mol Pharm) Vol. 11 Issue 8 Pg. 2612-22 (Aug 04 2014) ISSN: 1543-8392 [Electronic] United States
PMID24521262 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cations
  • GATA2 Transcription Factor
  • GATA2 protein, human
  • Polymers
  • RNA, Small Interfering
Topics
  • Animals
  • Apoptosis
  • Biological Transport
  • Carcinoma, Non-Small-Cell Lung (drug therapy, genetics)
  • Cations
  • Cell Line, Tumor
  • Cell Proliferation
  • GATA2 Transcription Factor (metabolism, therapeutic use)
  • Gene Silencing
  • Genes, ras
  • Hepatocytes (metabolism)
  • Humans
  • Lung Neoplasms (drug therapy, genetics)
  • Mice, Nude
  • Microscopy, Confocal
  • Mutation
  • Nanomedicine (methods)
  • Nanoparticles (chemistry)
  • Polymers (chemistry)
  • RNA Interference
  • RNA, Small Interfering (metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: